Experience from a randomized controlled trial with Impella 2.5 versus IABP in STEMI patients with cardiogenic pre-shock. Lessons learned from the IMPRESS in STEMI trial

Int J Cardiol. 2016 Jan 1:202:894-6. doi: 10.1016/j.ijcard.2015.10.063. Epub 2015 Oct 9.

Authors

D M Ouweneel¹, A E Engstrom¹, K D Sjauw¹, A Hirsch¹, J M Hill², B Gockel³, V Tuseth⁴, R J van der Schaaf⁵, J P S Henriques⁶

Affiliations

¹ Academic Medical Center, University of Amsterdam, AMC Heartcenter, Amsterdam, The Netherlands.
² King's College Hospital, London, UK.
³ The Bielefeld Hospital, Bielefeld, Germany.
⁴ Haukeland University Hospital, Bergen, Norway.
⁵ Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
⁶ Academic Medical Center, University of Amsterdam, AMC Heartcenter, Amsterdam, The Netherlands. Electronic address: [email protected].

PMID: 26476989
DOI: 10.1016/j.ijcard.2015.10.063

No abstract available

Keywords: Cardiogenic shock; Impella; Intra-aortic balloon pump; Mechanical support; Randomized controlled trial.

Publication types

Comparative Study
Letter
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Female
Heart-Assist Devices* / standards
Humans
Internationality*
Intra-Aortic Balloon Pumping / methods*
Intra-Aortic Balloon Pumping / standards
Learning*
Male
Middle Aged
Shock, Cardiogenic / diagnosis*
Shock, Cardiogenic / surgery*